Autolus Therapeutics (AUTL) Change in Cash (2018 - 2025)
Autolus Therapeutics' Change in Cash history spans 5 years, with the latest figure at $18.0 million for Q4 2025.
- For Q4 2025, Change in Cash rose 104.19% year-over-year to $18.0 million; the TTM value through Dec 2025 reached -$123.2 million, down 968.26%, while the annual FY2025 figure was -$123.2 million, 968.26% down from the prior year.
- Change in Cash reached $18.0 million in Q4 2025 per AUTL's latest filing, up from -$37.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $519.2 million in Q1 2024 to a low of -$429.7 million in Q4 2024.
- Average Change in Cash over 4 years is -$4.4 million, with a median of -$37.7 million recorded in 2025.
- The largest YoY upside for Change in Cash was 1417.59% in 2024 against a maximum downside of 2502.23% in 2024.
- A 4-year view of Change in Cash shows it stood at $219.4 million in 2022, then plummeted by 107.53% to -$16.5 million in 2023, then crashed by 2502.23% to -$429.7 million in 2024, then soared by 104.19% to $18.0 million in 2025.
- Per Business Quant, the three most recent readings for AUTL's Change in Cash are $18.0 million (Q4 2025), -$37.7 million (Q3 2025), and $28.1 million (Q2 2025).